DCP Logo
  • Home
  • About
    • DCP program
    • DCP program history
    • Structural Genomic Consortium
    • Probe contributions
  • Show Probes
    • All
    • Kinase
    • GPCR
    • Ion channel
    • Epigenetics
    • Other enzymes
    • Other targets
  • Order set
  • Download
  • Information
    • FAQ
    • Probe resources
    • Donate probes
    • Contact
    • Funding
    • Update history
All probes Probe criteria Further information Usage Order Properties Structure Potency Selectivity Data download
  • Probe criteria
  • Further information
  • Usage
  • Order
  • Properties
  • Structure
  • Potency
  • Selectivity
  • Data download

Usage recommendations for probe BAY-439 and control BAY-163


In cells

Use at a concentration up to 300 nM.

Use the recommended concentration to avoid off-target toxicity and/or off-target activity. Using concentrations that are higher than recommended could lead to false positive or confounding results.

In vivo

For in vivo studies in rat, use a maximum dose of 6 mg/kg. This dosage effectively covers the IC50 and is well tolerated for up to 7 days. However, extending the dosing period beyond 7 days lead to increased mortality rates in rodents for reasons that remain unresolved. Oral administration of BAY-439 (2-days QD treatment) reduced inflammatory pain in the complete Freund’s adjuvant (CFA)-induced arthritic rat model rat.